Surgical Science Sweden AB (publ) (SUS.ST)
SEK 108.6
(-6.54%)
SEK 108.6
(-6.54%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 233.97 Million SEK | 24.47% |
| 2022 | 187.97 Million SEK | 117.95% |
| 2021 | 86.24 Million SEK | 452.66% |
| 2020 | 15.6 Million SEK | 23.88% |
| 2019 | 12.59 Million SEK | 378.78% |
| 2018 | -4.51 Million SEK | -100.13% |
| 2017 | -2.25 Million SEK | -168.42% |
| 2016 | 3.3 Million SEK | 106.25% |
| 2015 | 1.6 Million SEK | 152.69% |
| 2014 | -3.03 Million SEK | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 23.79 Million SEK | -75.71% |
| 2024 Q2 | 28.56 Million SEK | 20.07% |
| 2023 Q3 | 47.4 Million SEK | 22.21% |
| 2023 FY | 233.97 Million SEK | 24.47% |
| 2023 Q1 | 49.81 Million SEK | -57.24% |
| 2023 Q2 | 38.78 Million SEK | -22.14% |
| 2023 Q4 | 97.96 Million SEK | 106.66% |
| 2022 Q1 | 16.47 Million SEK | -75.37% |
| 2022 FY | 187.97 Million SEK | 117.95% |
| 2022 Q4 | 116.52 Million SEK | 308.8% |
| 2022 Q3 | 28.5 Million SEK | 7.67% |
| 2022 Q2 | 26.47 Million SEK | 60.64% |
| 2021 Q2 | 3.46 Million SEK | 127.23% |
| 2021 Q1 | 1.52 Million SEK | -85.57% |
| 2021 FY | 86.24 Million SEK | 452.66% |
| 2021 Q4 | 66.89 Million SEK | 365.57% |
| 2021 Q3 | 14.36 Million SEK | 314.9% |
| 2020 Q1 | -684 Thousand SEK | -107.4% |
| 2020 Q3 | 5.94 Million SEK | 2890.14% |
| 2020 Q4 | 10.56 Million SEK | 77.69% |
| 2020 FY | 15.6 Million SEK | 23.88% |
| 2020 Q2 | -213 Thousand SEK | 68.86% |
| 2019 Q1 | -5.05 Million SEK | -281.73% |
| 2019 FY | 12.59 Million SEK | 378.78% |
| 2019 Q3 | 10.18 Million SEK | 674.39% |
| 2019 Q4 | 9.24 Million SEK | -9.26% |
| 2019 Q2 | -1.77 Million SEK | 64.92% |
| 2018 Q2 | -1.8 Million SEK | 60.0% |
| 2018 FY | -4.51 Million SEK | -100.13% |
| 2018 Q3 | -1 Million SEK | 44.44% |
| 2018 Q4 | 2.78 Million SEK | 378.1% |
| 2018 Q1 | -4.5 Million SEK | -206.08% |
| 2017 Q4 | 4.24 Million SEK | 224.76% |
| 2017 Q1 | -600 Thousand SEK | -105.56% |
| 2017 FY | -2.25 Million SEK | -168.42% |
| 2017 Q2 | -2.5 Million SEK | -316.67% |
| 2017 Q3 | -3.4 Million SEK | -36.0% |
| 2016 Q2 | -2.2 Million SEK | -100.0% |
| 2016 Q1 | -1.1 Million SEK | 0.0% |
| 2016 Q3 | -4.2 Million SEK | -90.91% |
| 2016 FY | 3.3 Million SEK | 106.25% |
| 2016 Q4 | 10.8 Million SEK | 357.14% |
| 2015 FY | 1.6 Million SEK | 152.69% |
| 2014 FY | -3.03 Million SEK | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Aino Health AB (publ) | -10.66 Million SEK | 2294.653% |
| Bonzun AB (publ) | 13.88 Million SEK | -1585.146% |
| Kontigo Care AB (publ) | 212 Thousand SEK | -110264.151% |
| Medhelp Care Aktiebolag (publ) | -11.01 Million SEK | 2225.086% |
| RaySearch Laboratories AB (publ) | 81.57 Million SEK | -186.829% |